- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/32 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
Patent holdings for IPC class C07D 211/32
Total number of patents in this class: 256
10-year publication summary
|
15
|
22
|
20
|
16
|
15
|
10
|
20
|
9
|
5
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Theravance Biopharma R&D IP, LLC | 408 |
17 |
| Incyte Holdings Corporation | 626 |
9 |
| Incyte Corporation | 1068 |
8 |
| Merck Sharp & Dohme LLC | 3728 |
6 |
| Glaxosmithkline LLC | 528 |
5 |
| Janssen Pharmaceutica N.V. | 3177 |
5 |
| Arvinas Operations, Inc. | 262 |
5 |
| F. Hoffmann-La Roche AG | 7832 |
4 |
| Boehringer Ingelheim International GmbH | 4501 |
4 |
| Merck Patent GmbH | 5725 |
4 |
| National University Corporation Hokkaido University | 1362 |
4 |
| The Regents of the University of California | 20690 |
3 |
| Nerviano Medical Sciences S.r.l. | 236 |
3 |
| The United States Government AS represented by The Department of Veterans Affairs | 1328 |
3 |
| Zhejiang Huahai Pharmaceutical Co., Ltd. | 218 |
3 |
| Universite de Caen Normandie | 127 |
3 |
| Eccogene Inc. | 11 |
3 |
| Bristol-myers Squibb Company | 4721 |
2 |
| Genentech, Inc. | 4101 |
2 |
| Syngenta Limited | 429 |
2 |
| Other owners | 161 |